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Abstract Corrected QT interval (QTc) prolongation is
long considered as a predisposing factor for the occurrence
of torsade de pointes (TdP) and sudden cardiac arrest in
methadone maintenance treatment. We aimed to elucidate
the correlation between QTc prolongation and in-hospital
death, respiratory arrest, and endotracheal intubation in
acute methadone-intoxicated patients presenting to the
emergency department and to assess the value of QTc in
predicting these outcomes. A prospective cross-sectional
study with a convenience sample of patients with acute
methadone overdose was done. Participants were 152
patients aged 15–65 with negative urinary dipstick test for
cyclic antidepressants, no history of other QTc-prolonging
conditions and co-ingestions, no severe comorbidities
affecting the outcomes, and positive urinary dipstick results
for methadone. QTc intervals were measured and
calculated in triage-time electrocardiogram (ECG). Death
was correlated with QTc (P = 0.014) and length of ICU
admission (P \ 0.001). In multivariable analysis, death
was independently associated only with length of ICU
admission [odds ratio (OR) 95 % confidence intervals
(95 % CI) 1.36 (1.14–1.61)]. Intubation and respiratory
arrest were independently associated with QTc interval
[OR (95 % CI) 1.03 (1.02–1.04) and 1.02 (1.01–1.03),
respectively]. The receiver operating characteristics curves
drawn to show the ability of QTc to predict death, intu-
bation, and respiratory arrest showed thresholds of 470,
447.5, and 450 ms with sensitivity (95 % CI) and speci-
ficity (95 % CI) of 87.5 (47.3–99.7), 86.8 (74.7–94.5), and
77.3 (62.2–88.5), respectively. Our study showed that QTc
is a potential predictor for adverse outcomes related to
acute methadone intoxication. The correlations shown in
this study between triage-time QTc and in-hospital respi-
ratory arrest or intubation in methadone overdose may be
of clinical value, whether these outcomes are hypothesized
to be a reflection of background TdP or intoxication
severity.
Keywords Methadone  Opioid-related disorders 
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Introduction
Corrected QT interval (QTc) prolongation, whether con-
genital or acquired, is long considered as a predisposing
factor for the occurrence of torsade de pointes (TdP) and
sudden cardiac arrest. Some studies have shown the asso-
ciation of QTc prolongation and mortality in intentional
organophosphate poisoning, syncope, suspected acute non-
specific intoxications, and after ischemic strokes [1–4].
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Others have evaluated QTc prolongation as a well-known
complication of methadone consumption in methadone
maintenance treatment (MMT) for opioid addiction absti-
nence compared to other equivalently used agents such as
buprenorphine [5]. Some studies have led to development
of routine follow-up programs to screen for QTc prolon-
gation and discontinue methadone if critical levels are
detected [6–12].
In acute methadone overdose, some risk factors for
mortality have been described including female sex, lack of
concurrent heroin involvement, overdosing during the
weekend, recent leaving of MMT, syrup formulation, and
the presence of CYP2B6 and l-opioid receptor (OPRM1)
gene variations [13–16]. In the current literature, however,
the main concern in QTc prolongation is its association
with TdP and sudden cardiac arrest in MMT programs
using methadone on a regular basis, as reviewed by Krantz
et al. [7].
In MMT programs, QTc prolongation appears to be
related primarily to daily methadone dose, but concomitant
administration of CYP3A4 inhibitors, hypokalemia, hepa-
tic failure, administration of other QT-prolonging drugs,
and pre-existing heart disease also appear to play a role [6,
16–18]. In one cross-sectional study on 450 patients
receiving methadone, the odds ratio for developing syn-
cope was 1.2 times greater with each 50 mg increment in
the daily dose [9]. The QTc reaching 470–490 ms or an
increase in at least 60 ms from baseline is proposed as a
critical level in another study [19]. There is no universal
consensus on the QTc cutoff point showing increased
incidence of TdP, but most experts mention 500 ms as the
alarming value [7].
In this cross-sectional study, a longer QTc interval is
hypothesized as a potential indicator of intoxication
severity in acute methadone overdose. Therefore, this study
is designed to answer the following research question: Can
the presence of QTc prolongation at triage predict adverse
clinical outcomes such as death, respiratory arrest, or
endotracheal intubation in patients with acute methadone
intoxication?
Materials and Methods
Study Design and Settings
This was an analytic cross-sectional study conducted in
Loghman-Hakim Hospital Poison Center (LHHPC) in
Tehran from March 1, 2011, to February 30, 2012. The
Loghman-Hakim toxicology unit serves a population in
excess of 12.5 million and has an annual ED census of
more than 30,000 with about 14,000 hospital admissions. It
is the main tertiary hospital for poisoned patients in the
capital city and is the largest in the country. This institution
has one of the largest and busiest inpatient toxicology
facilities in the world [16, 20–22].
This study was approved by Tehran University of
Medical Sciences Institutional Review Board.
Selection of Participants
Patients were recruited during 2 days per week (conve-
nience sampling). All patients presenting to ED with a
history of methadone intoxication were considered for
enrollment. Intoxication or overdose was defined as
ingestion of more than 10 mg of methadone in recently
non-users (not using methadone within one previous
month) or more than usual doses in previous consumers,
making them or their companions seek help. A urine dip-
stick test for methadone for each patient was being done
after admission, and patients with negative results were
being excluded from the study.
Exclusion criteria were defined as the following: unre-
liable/unobtainable history, negative urine dipstick results
for methadone, presence of significant comorbid illnesses
affecting survival or adverse outcomes (e.g., severe heart
disease), ages under 15 (excluding pediatric condition,
which may be different from adults in several parameters)
or over 65 (minimizing the impact of comorbid conditions
on results), history of co-ingestions for other known QTc-
prolonging drugs or drugs obviously affecting the out-
comes (e.g., benzodiazepine overdose makes patients more
prone to intubation because of respiratory depression),
hypokalemia or hyperkalemia, positive urine dipstick
results for cyclic antidepressants, and finally changes in
diagnosis during the admission period (Fig. 1). As could be
seen in our exclusion criteria, we tried to omit all signifi-
cant multidrug overdoses from our population based on
history and dipstick test results.
Study Protocol
For each patient presenting to ED with the history of
methadone overdose or suspicious for this diagnosis,
complete vital signs were documented by the emergency
physician [resident of emergency medicine, postgraduate
year (PGY) 3] and an ECG and other initial laboratory tests
[including blood gas, blood sugar (BS), electrolytes, blood
urea nitrogen (BUN), creatinine (Cr), and liver function
tests] were obtained. From this collection of patients, only
those who were visited by one of the investigators (based
on availability) were enrolled. In the time of visit, a
comprehensive history and physical examination in addi-
tion to urinary dipstick tests for methadone (W.H.P.M., Inc,
USA, cutoff: 300 ng/mL), cyclic antidepressants
(W.H.P.M., Inc, USA, cutoff: 1,000 ng/mL), tramadol
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(Rojan, IRAN, cutoff: 100 ng/mL) morphine (Rojan,
Iran, cutoff: 300 ng/mL), and benzodiazepines (W.H.P.M.,
Inc, USA, cutoff: 300 ng/mL) were performed to further
confirm the diagnosis. The presence or absence of other
QTc-prolonging conditions as well as central nervous
system (CNS) pathologies and risk factors for respiratory
failure (e.g., drugs and pulmonary diseases) were assessed.
The data collecting team consisted of a resident of emer-
gency medicine (PGY3), and two medical students directly
supervised by an attending physician of clinical toxicology.
The research staffs were specifically trained to obtain a
comprehensive history, to perform a systematic clinical
examination, and to perform and interpret urine dipstick
tests. The enrolled patients were visited frequently (every
2–3 h on average) by one of the investigation team mem-
bers throughout their hospitalization.
Although some patients admitted and discharged with
the diagnosis of acute methadone overdose during study
period were missed because of lack of 24-h coverage by
investigators, this method of data collection was preferred
over a retrospective study of all patients for two main
reasons: First, performing the history taking, physical
examinations, and dipstick tests by researchers and fol-
lowing the hospital course events provide more reliable
data over simply reviewing files. Second, most patients
with acute methadone overdose and more complicated
course were hospitalized long enough to be enrolled by the
investigators. Therefore, patients missed by the research
team are more likely to have an uncomplicated course and
short hospital length of stay.
Electrocardiographic Evaluation
Only those ECGs done in the first few minutes of pa-
tientsaˆ€TM arrival were evaluated. All QT interval readings
and QTc calculations were performed by two board-certi-
fied emergency medicine specialists experienced in ECG
interpretation and blinded to the study protocol and
patients. A standard 12 lead ECG was done for each
patient, and all standard leads were evaluated by these two
physicians [23]. All ECGs were reviewed by both of the
readers, and the inter-observer agreements were calculated.
The device used to obtain ECG in LHPC ED was not able
to calculate QTc automatically, so there were no printed
records on strips distracting the ECG evaluators. QTc
intervals were calculated by Bazett formula. Disagreements
were resolved by consensus, or in a small number of
patients, especially in the case of abnormal T waves or T–
U wave fusions, by eliminating the unclear lead(s) from
evaluation if both of the readers vote for elimination.
However, in a few cases, no agreement could be reached,
which resulted in exclusion of those patients from the study
(see Results).
There is no universal consensus on the limits defining a
prolonged QTc interval or a threshold below which there
might be no chance for TdP to develop. However, a QTc
interval of more than 430 ms for males and 470 ms for
females, or independent of sex, above 450 ms is considered
as prolonged QTc interval [7].
Patient Management and Disposition
The researching team did not participate in management or
disposition of the patients. The decision to intubate a patient
in LHHPC ED is made by the emergency medicine residents
according to universal indications and hospital protocols
under direct supervision of clinical toxicology fellows or
Methadone poisoned
patients
n = 244
Eligible patients
n = 233
Not included:
n = 11
Age<15 (n=4)
Age>65 (n=7)
Excluded: n=81
Ingestion<10 mg (n=5)
Unreliable/unobtainable history
(n=13)
Positive for TCA,fluoroquinolones,
macrolides, fluoxetine, or
antipsychotics (n=21-5, fivecases
overlapping with co-morbid
illnesses)
Hypokalemia (n=3)
Hyperkalemia(n=1-1),overlapping
with co-morbid illnesses
Negative dipstick for Methadone
(n=3)
Co-morbid illnesses or Previous
ECG abnormalities (n=7)
Remaining disagreement in QTc
measurement (n=4)
Changes in diagnosis (n=11)
Benzodiazepine overdose (n=19)
Included patients
n=152
114(75%) males,
38(25%) females
Previous consumers (n=74)
No history of recent
methadone consumption
(n=64)
Unidentified (n=14)
Fig. 1 Step-by-step exclusion of patients to reach the study
population
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attending physicians (see Study outcomes). Patient dispo-
sition follows the same process. In medical toxicology ICUs,
the decision making for management and disposition is
made directly by toxicology fellows or attending physicians.
Study Outcomes
The primary outcomes of the study were in-hospital mor-
tality, respiratory arrest, and orotracheal intubation. All
respiratory depressions with no effective breathing, urging
the need for immediate intervention (primarily non-invasive
ventilation and intravenous naloxone administration) were
categorized under respiratory arrest title. Intubation and
mechanical ventilation are mainly performed for patients
presenting with respiratory depression refractory to nalox-
one and non-invasive ventilatory support and those at sig-
nificant risk of aspiration or impending airway compromise.
Statistical Analysis
Values are reported as mean ± SD for normally distributed
continuous variables or median and interquartile range (IQR)
for other non-normally distributed continuous variables.
Proportions are presented as percentages with 95 % confi-
dence intervals (CI). For univariate analysis, continuous data
were analyzed using the Studentaˆ€TMs t test if the data were
normally distributed (according to the Kolmogorov–Smir-
nov and Shapiro and Leveneaˆ€TMs tests); otherwise, the
adjusted t test was used. Categorical data were compared
using Pearson I¨2 test. A P value less than 0.05 was con-
sidered to be statistically significant. To establish the mag-
nitude and direction of the three major outcomes, we
calculated the odds ratio (OR and its 95 % CI). The multi-
variable analysis was performed by constructing a logistic
regression model. All variables showing significant corre-
lation with outcomes in univariate analysis were also tested
in multivariable analysis. In multivariable model, we entered
all variables with P value \0.2 in their univariate analysis
with our outcomes. We run two separate logistic models for
each outcome. One full logistic model with enter method and
one model with only significant variables according to for-
ward Wald method. Receiver operating characteristic (ROC)
curves were generated to test the ability of QTc in predicting
the outcomes of death, intubation, or respiratory arrest.
Statistical analysis was performed by Statistical Package for
the Social Sciences for Windows version 17.0 (SPSS Inc.
Headquarters, Chicago, IL) software program.
Sample Size Analysis
According to the formula of sample size calculation for
diagnostic tests, considering a sensitivity of 0.8, a
specificity of 0.8, Iˆ± = 0.05, and QTc being useful if
positive likelihood ratio (PLR) is equal or higher than 2.52,
sample size was estimated to be 152 cases.
Results
A total of 152 from 244 methadone-intoxicated patients
who presented to ED in the sampling days (2 days a week)
were enrolled in the study (92 were excluded, see Fig. 1)
from March 1, 2011, to February 30, 2012, with an age
range of 15–65 years. Male patients were significantly
older (36.3 ± 11.8 vs. 28.7 ± 13.9 years, P = 0.002).
QTc more than 450 ms was observed in 77 (50.7 %) cases.
Basic characteristics of the cases are presented in Table 1.
Two patients were found to develop TdP during hospi-
talization. The duration of TdP in the first patient was 15 s
in ICU, and the second patient developed a 5–10 s episode
in ED. Both patients had been intubated before TdPs
observed, and the sinus rhythm was recovered before any
acute intervention made.
Univariate Analysis
There were 8 deaths, 44 respiratory arrests, and 53 cases
which were intubated during admission course. The docu-
mented mechanisms of death, diagnosed by physicians in
charge of the patients, are shown in Table 2. Death was
correlated with QTc interval in presenting ECG
(P = 0.014) and length of ICU admission (P \ 0.001).
Being intubated during admission course was also corre-
lated with co-ingestions (P = 0.016), abnormal respiration
(P \ 0.001), decreased consciousness (P \ 0.001), QTc
intervals more than 450 ms (P \ 0.001), intoxication
dosage (P = 0.014), QTc interval in presenting ECG
(P \ 0.001), length of hospitalization (P \ 0.001), and
length of ICU admission (P \ 0.001). There were also
some correlations found for respiratory arrest during
admission (Tables 3 and 4). However, because there are
multiple comparisons here, an adjusted analysis was done
to find independent associations (see below). All variables
found to have correlation with outcomes in univariate
analysis were also tested in multivariable analysis.
Adjusted Analysis
The most important independent variable for predicting
death was the length of ICU admission. For predicting
intubation risk, QTc interval on arrival had the highest
predictive value, and for predicting respiratory arrest, the
QTc interval on arrival and hours from ingestion were
shown to be the most important variables (Table 5). The
OR of 1.36 (95 %CI 1.14–1.61) means that each additional
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day of staying in ICU increases the risk of death by
14–61 %. Each millisecond increase in QTc interval in
arrival-time ECG increases the risk of intubation by 1–3 %
and the risk of respiratory arrest by 2–4 %.
To evaluate the diagnostic accuracy of QTc interval for
death, we used ROC curves to determine the best cut point
with highest simultaneous sensitivity and specificity
(Table 6; Fig. 2). According to the table, a threshold of
Table 1 Basic characteristics of the patients
Signs Values
Age, mean (SD) (year) 34.4 (12.7)
Male gender, No. (%) 114 (75)
Type of methadone ingestion, No. (%)
Acute with no history of previous ingestions 64 (42.1)
Acute on chronic, with history for previous
ingestions
74 (48.7)
Undetermined 14 (9.2)
QTc interval range (ms) 300–611
QTc, median (IQR) (ms) 450 (54)
Methadone ingestion dosage, median (IQR) (mg) 80 (100)
Arrival time to the emergency from ingestion,
median (IQR) (hour)
8 (7)
Pulse rate (mean ± SD) 84 ± 17.6
Respiratory rate (mean ± SD) 21.3 ± 9.2
Systolic blood pressure (mean ± SD) 119.7 ± 18
Glasgow coma score (mean ± SD) 13.5 ± 2.5
Respiratory arrest after disposition from ED, No.
(%)
15 (9.9)
Total respiratory arrests, No. (%: 95 % CI) 44 (28.9:
21.6-36.3)
Hospitalization period, median (IQR) (days) 3 (3)
Patients transferred to ICU, No. (%: 95 % CI) 57 (37.5:
30.5-46.5)
length of ICU stay, median (IQR) (days) 5 (5)
Deaths, No. (%: 95 % CI) 8 (5.3: 1.6-8.9)
Tachycardia, No. (%) 26 (17.1)
Tachypnea, No. (%) 13 (8.6)
Bradypnea, No. (%) 3 (2)
Apnea, No. (%) 1 (0.7)
Hypotension, No. (%) 7 (4.6)
Consciousness level at presentation, No. (%)
15 56 (36.8)
13–14 35 (23)
9–13 24 (15.8)
5–9 22 (14.5)
3–5 12 (7.9)
* Sum of percents do not reach 100 % in some cases because of
presenting missing value
IQR inter quartile range, mg milligram, ms millisecond, No. number,
SD standard deviation
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470 ms can provide a sensitivity of 87.5 % and specificity
of 74.3 %, with the area under curve for QTc higher than
470 ms being 0.85 for detecting mortality. The same curve
for the diagnostic accuracy of QTc for intubation showed a
cutoff of 447.5 ms with a sensitivity of 86.8 % and a
specificity of 67.7 %, with the area under curve being 0.80
(Table 4; Fig. 2). ROC curve for QTc in identifying
respiratory arrest (Fig. 2) found a cutoff of QTc equal or
higher than 450.5 to be associated with sensitivity and
specificity of 77.3 and 63 %, respectively, with area under
the curve being 0.728.
There was good inter-observer agreement between the
two ECG readers (kappa coefficient: 0.81). Four cases with
remaining disagreement were discarded.
Table 3 Association between
death, respiratory arrest, and
intubation with qualitative
variables
Bold values indicate statistically
significant (p \ 0.05)
n number
* P = 0.053; § P = 0.062,
these ORs have borderline
significance
Dependent variable Independent variable Crude OR (95 % CI)
Death (n = 8) Abnormal laboratory test 3.47 (0.82–14.69)
Syrup form of the drug in comparison with tablet 5.49 (0.62–47.62)
Co-ingestion 1.51 (0.35–6.56)
Abnormal pulse rate 0.66 (0.08–5.63)
Abnormal respiration 1.18 (0.23–6.15)
Hypotension 0.23 (0.002–675.12)
Decreased consciousness 4.48 (0.54–37.39)
Naloxone infusion 32 (0.91–453.83)
Abnormal ABG 1.22 (0.24–6.30)
Borderline/prolonged QTc interval 7.4 (0.89–61.69)
Female gender 1 (0.19–5.18)
Type of ingestion acute on chronic in comparison
with acute
2.25 (0.42–12)
Respiratory arrest
(n = 44)
Abnormal laboratory test 2.21 (0.98–4.98)*
Syrup form of the drug in comparison with tablet 1.12 (0.53–2.40)
Co-ingestion 1.90 (0.91–3.98)
Abnormal pulse rate 0.72 (0.27–1.95)
Abnormal respiration 1.64 (0.72–3.73)
Hypotension 1.02 (0.19–5.47)
Decreased consciousness 5.51 (2.14–14.14)
Naloxone infusion 6.04 (1.55–23.55)
Abnormal ABG 1.29 (0.56–2.96)
Borderline/prolonged QTc interval 6.11 (2.67–14)
Female gender 0.7 (0.3–1.63)
Type of ingestion acute on chronic in comparison
with acute
1.09 (0.52–2.32)
Intubation (n = 53) Abnormal laboratory test 1.85 (0.85–4.06)
Syrup form of the drug in comparison with tablet 0.62 (0.29–1.33)
Co-ingestion 2.36 (1.16–4.77)
Abnormal pulse rate 2.24 (0.95–5.28)§
Abnormal respiration 4.22 (1.88–9.49)
Hypotension 2.70 (0.58–12.54)
Decreased consciousness 31.40 (7.23–136.41)
Naloxone infusion 3.11 (0.54–17.80)
Abnormal ABG 1.18 (0.54–2.54)
Borderline/prolonged QTc interval 14.42 (5.85–35.51)
Female gender 0.96 (0.44–2.08)
Type of ingestion acute on chronic in comparison
with acute
0.70 (0.35–1.42)
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Discussion
A large body of literature is dedicated to QTc prolongation
in MMT and its association with TdP. The studies done by
several researchers showed that there should be a special
concern to screen for QTc prolongation in MMT programs,
leading to the formation of cardiac safety recommenda-
tions for physicians prescribing methadone by Krantz et al.
[7]. These recommendations, however, do not include
acute intoxications.
ED physicians frequently encounter patients with his-
tory of drug overdose for whom a detailed history (type of
drug, dose, co-ingestions, etc.) could not be obtained. In
such situations, variables that could predict the adverse
clinical outcomes could be very helpful. Our study showed
that QTc is a potential predictor for adverse outcomes
related to methadone intoxication. Prolongation of QTc
interval could also be considered an adverse outcome of
methadone consumption due to its direct association with
TdP. A study in Tehran found acute methadone overdose
as the most common cardiotoxic drug, in which QT dis-
persion was the most specific tool that could successfully
predict development of the complications [24].
Our study shows a correlation between QTc interval and
in-hospital mortality, intubation risk, and respiratory arrest,
but the logistic regression analysis did not show an inde-
pendent association between QTc interval and mortality.
One explanation for this may be a low number of deceased
patients in our study, reducing our ability to show any
independent association. However, our clinical experience
makes us still believe there should be a strong consider-
ation for close observation and monitoring of acute or
acute on chronic methadone intoxications with initial QTc
more than 450–470 ms, as our findings regarding intuba-
tion and respiratory arrest and their independent associa-
tion with QTc make us more cautious about this matter.
The predicting capability of QTc on arrival for respiratory
arrest or need for intubation is particularly important for
patients developing these complications after disposition
from ED (see Results: Basic characteristics). These find-
ings allow us to predict the adverse outcomes early on and
take necessary precautions.
The correlation and independent association between
QTc prolongation and respiratory arrest may be a point of
consideration. Logically, there may not be a direct asso-
ciation between an ECG feature and an outcome such as
respiratory arrest, and the occurrence of respiratory arrest
may be attributed to co-ingestions or drugs administered
for sedation. However, we have found such an association
in the absence of any documented confounding factor;
there is a strong consideration that the QTc may be a
representative of the severity of intoxication, and increases
in overdose severity affect the respiratory status of theT
a
b
le
4
A
ss
o
ci
at
io
n
b
et
w
ee
n
d
ea
th
,
ar
re
st
,
an
d
in
tu
b
at
io
n
w
it
h
q
u
an
ti
ta
ti
v
e
v
ar
ia
b
le
s
D
ea
th
(n
=
8
)
A
rr
es
t
(n
=
4
4
)
In
tu
b
at
io
n
(n
=
5
3
)
Y
es
N
o
Y
es
N
o
Y
es
N
o
A
g
e
3
2
.5
(2
4
.4
–
4
0
.6
)
3
4
.5
(3
2
.4
–
3
6
.7
)
3
6
(3
1
.8
–
4
0
.1
)
3
3
.8
(3
1
.4
–
3
6
.1
)
3
5
.5
(3
1
.6
–
3
9
.5
)
3
3
.8
(3
1
.4
–
3
6
.3
)
In
to
x
ic
at
io
n
d
o
se
3
0
0
a
1
3
9
(1
0
0
.3
–
1
7
7
.6
)
1
7
4
.2
(7
6
.2
–
2
7
2
.2
)
1
2
9
.6
(8
8
.7
–
1
7
0
.4
)
1
8
7
(9
2
.9
–
2
8
1
.1
)
1
2
4
.5
(8
3
.5
–
1
6
5
.5
)
H
o
u
rs
fr
o
m
in
g
es
ti
o
n
9
.3
(5
.2
–
1
3
.5
)
8
.8
(7
.9
–
9
.8
)
1
0
.3
(8
.8
–
1
1
.9
)
8
.3
(7
.2
–
9
.4
)
9
.8
(8
.3
–
1
1
.2
)
8
.5
(7
.3
–
9
.6
)
Q
T
c
in
te
rv
al
in
p
re
se
n
ti
n
g
E
C
G
4
8
8
.5
(4
5
4
.8
–
5
2
2
.2
)
4
4
7
.6
(4
4
0
.1
–
4
5
5
.1
)
4
7
1
.8
(4
6
0
.9
–
4
8
2
.7
)
4
4
0
.8
(4
3
1
.9
–
4
4
9
.7
)
4
7
9
.2
(4
6
8
.1
–
4
9
0
.3
)
4
3
4
(4
2
5
.8
–
4
4
2
.1
)
L
en
g
th
o
f
h
o
sp
it
al
iz
at
io
n
1
5
(5
–
2
5
)b
4
.3
(3
.6
–
4
.9
)
8
.4
(6
.5
–
1
0
.2
)
3
.1
(2
.6
–
3
.6
)
8
.4
(6
.9
–
9
.9
)
2
.5
(2
.2
–
2
.9
)
L
en
g
th
o
f
IC
U
ad
m
is
si
o
n
1
5
.8
(3
.7
–
2
7
.8
)
2
.1
(1
.5
–
2
.7
)
6
.8
(4
.9
–
8
.7
)
0
.9
(0
.4
–
1
.3
)
7
.2
(5
.7
–
8
.7
)
0
.2
(0
.0
4
–
0
.3
)
V
al
u
es
ar
e
m
ea
n
(9
5
%
C
I)
n
n
u
m
b
er
a
T
h
er
e
w
as
o
n
ly
o
n
e
ca
se
b
H
er
e,
th
er
e
w
er
e
tw
o
ca
se
s,
an
d
v
al
u
es
ar
e
m
in
im
u
m
an
d
m
ax
im
u
m
364 Cardiovasc Toxicol (2014) 14:358–367
123
patient during the admission period. Another hypothesis,
however, could be the sequential order of cardiac arrest
due to TdPs and the following respiratory arrest which,
without intense monitoring, could be indistinguishable
from a primary respiratory arrest since TdPs are mostly
self-limited. Our study had not been designed to test such a
cause and effect hypothesis, and the telemetry data were no
longer available for review at the end of the study.
There were found two cases with TdP during hospital-
ization course. However, these episodes did not result in
death. It must be noted that this study was not designed to find
TdPs, and we may have some other undetected ones as well.
A number of limitations must be noted. First, the con-
venience sampling method subjects our study to sampling/
spectrum bias, since some patients with less severe
intoxications and less complicated hospital course might
not have been enrolled. This might artificially inflate the
ability of QTc to predict adverse events, as presumably
well patients, without adverse outcomes, were primarily
missed by these methods. The relatively high percentages
of morbidity and mortality in this study could also be
explained by this method of sampling and also by the fact
that our study has been performed in a large tertiary center
which has a naturally higher number of severe intoxica-
tions. Second, performing a dipstick test for methadone has
its own limitations. The test may only show exposure to
this agent in recent days but not serum methadone levels.
In addition, false-positive and false-negative results are not
uncommon. Third, using the Bazett formula for heart rates
more than 100 bpm tends to overcorrect QTc, but since our
target was to document QTc at triage, we could not wait
for higher rates to be changed over time. In addition, the
physicians evaluating ECGs were obligated to evaluate the
Table 5 Logistic regression analysis of important outcomes (death,
arrest, and intubation)
Dependent
variable
Independent
variable
OR (95 % CI) Model
significancy
and
Nagelkerke
R-square
Death
(n = 8)
Length of ICU
admission
1.36 (1.14–1.61) \0.001, 0.504
Respiratory
arrest
(n = 44)
QTc interval in
presenting
ECG
1.02 (1.01–1.03)a \0.001, 0.205
Hours from
ingestion
1.11 (1.01–1.22)a
Intubation
(n = 53)
QTc interval in
presenting
ECG
1.03 (1.02–1.04) \0.001, 0.312
a Adjusted for intoxication dosage
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leads with more clear T wave morphologies in few cases
with abnormal T waves and T–U wave fusions, which may
potentially miss the longest QTc interval in 12 leads.
Lastly, the number of outcome events (especially death)
may not be enough to be included in a logistic regression
model and results regarding this point should be interpreted
with caution.
Our ROC curves are derived from the univariate analyses.
Generally, this is not a confirmatory study in this field
because there is no similar publication previously per-
formed. It is an exploratory study, and we have tried to
produce some hypotheses for future studies. We are not able
to recommend clinicians to implement our results in this step.
Further confirmatory studies are needed in this field for being
more confident to use these findings in clinical setting. Until
such data being provided, our information can be used only
as supplementary and auxiliary tool in clinical setting.
Our study presents a different aspect of QTc prolonga-
tion, which is the correlation between QTc in triage ECG
and some adverse outcomes apparently related to intoxi-
cation severity. This may apply to other intoxications as
well. A larger study is needed to clarify the association of
QTc and mortality.
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